Mr. Nolan joined Foundation Medicine in January 2016 as its senior vice president, Global Sales and brings with him more than two decades of experience in clinical diagnostics and a proven ability to develop and commercialize next generation sequencing technologies. His career has focused on delivering transformative and clinically useful solutions by applying diagnostic technologies to help medical care teams answer clinical questions.
Prior to joining Foundation Medicine, Mr. Nolan was most recently vice president and general manager, oncology at Thermo Fisher Scientific (formerly Life Technologies). Prior to Thermo Fisher Scientific, Mr. Nolan was with Luminex Corporation, where he led the global diagnostics business as vice president, diagnostic commercial operations. He joined Luminex from Roche Molecular Systems, where he served as senior director and international business leader, blood screening and also held positions with Roche Diagnostics Corporation that included U.S. director of marketing, molecular diagnostics and national director, molecular diagnostics. His experience prior to Roche includes sales and marketing positions of increasing responsibility within Abbott Laboratories’ Diagnostics Division; along with a senior leadership role at a company he helped to become venture-funded.
Mr. Nolan holds a B.S. in Biological Sciences and a MBA from the University of Wyoming.